MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia

    S. Rashid, D. Fletcher, J. Frey (Morgantown, USA)

    Objective: To assess telehealth patterns on socioeconomic and geographic factors and time to surgery in  patients with Parkinson’s Disease (PD) evaluated for deep brain stimulation…
  • 2026 International Congress

    Grip strength and hand distress in de novo Parkinson´s disease: support for early rehabilitation

    A. Szymanska, E. Franzén, L. Dahlin, S. Grigoriou, B. Lindholm (Malmö, Sweden)

    Objective: To describe grip strength and upper limb (UL) distress in de novo PD, and to explore associations with motor symptoms. Background: Grip strength is…
  • 2026 International Congress

    Diet Quality and Nutrient Intake in Parkinson’s Disease: A Multicenter Study in Egypt

    E. Abed (Cairo, Egypt)

    Objective: To compare diet quality and nutrient intake between PD patients and controls and examine associations with PD clinical features. Background: Parkinson’s disease (PD) is…
  • 2026 International Congress

    The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

    D. Prihananti, E. Pasmanasari (Semarang, Indonesia)

    Objective: This study aims to analyze the correlation between serum uric acid levels and the severity of Parkinson's disease. Background: Uric acid has been implicated…
  • 2026 International Congress

    Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

    E. Abed (Cairo, Egypt)

    Objective: Essential tremor (ET) is one of the most prevalent neurological disorders and has increasingly been linked to cognitive dysfunction. However, most existing data regarding…
  • 2026 International Congress

    Correlational Study of the Clinical Impression of Severity Index for Parkinson’s Disease (CISI-PD) with Functional Mobility Measures

    ZE. Chan, KCY. Yong, KP. Lim, JP. Chua, TS. Toh, AH. Tan, SY. Lim (Subang Jaya, Malaysia)

    Objective: To evaluate the correlation between CISI-PD by examining its association with four widely-validated functional mobility measures in PD: the 5 Times Sit-to-Stand Test (5xSTS),…
  • 2026 International Congress

    Integrating Multidisciplinary, Family-Centered Care to Optimize Functional Outcomes in Children with Cerebral Palsy.

    T. Voloshyn (TRUSKAVETS, Ukraine)

    Objective: Optimal management of Cerebral Palsy requires coordinated, evidence-based interventions that address both motor and non-motor domains across the lifespan.  Background: Randomized controlled trials (RCTs)…
  • 2026 International Congress

    Parkinson’s Disease Early Diagnostic and Prognostic Biomarkers Identified by Large-scale Plasma and Cerebrospinal Fluid Proteomic Profiling

    XY. Li, YL. Tang, J. Wang (Shanghai, China)

    Objective: To identify reliable diagnostic and prognostic protein biomarkers for early-stage Parkinson’s disease (PD) using large-scale proteomic profiling of plasma and cerebrospinal fluid (CSF).To identify…
  • 2026 International Congress

    Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks

    L. Wright, D. Burn, J. Taylor, J. O'Brien, A. Yarnall, M. Firbank, A. Thomas, R. Lawson (Newcastle, United Kingdom)

    Objective: Investigating how neuropsychiatric symptoms (NPS)—depression, anxiety, and apathy—relate to functional connectivity between monoaminergic nuclei and the limbic network (LN), default mode network (DMN), and…
  • 2026 International Congress

    Ulixacaltamide Demonstrates Superiority Over Placebo as Monotherapy and as Add-on to Propranolol in Essential Tremor: Phase 3 ESSENTIAL3 Study 1

    M. Souza, S. Petrou, M. Sniecinski, C. Santos, M. Giroux, M. Steidle, J. Farmer, S. Brillman, A. Shtilbans (Boston, USA)

    Objective: To evaluate efficacy of ulixacaltamide, a selective T-type calcium channel modulator, versus placebo in adults with essential tremor (ET) as monotherapy and as add-on…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley